Showing 177 Result(s)
夜上海论坛

Consumer Durables: Margins likely to start rising sequentially

Our Consumer Durables coverage universe posted a top-line beat versus our estimates, which on a 3Y-CAGR-basis stood at 7.9% (ex-Dixon/Amber). Profitability remained challenging – Ebitda margins dipped 180bp below our estimate, albeit flat y-o-y, owing to high-cost inventory, limited pricing action and higher ad-spends during the quarter. In our view, with commodity costs easing, margins …

夜上海论坛

Sebi rejigs market data advisory committee

Sebi has restructured its advisory committee on market data that recommends policy measures pertaining to securities market data access and privacy. The market data advisory committee will now have 20 members, the latest information on the Securities and Exchange Board of India’s (Sebi) website showed. Earlier, the committee had 21 members. Sebi has replaced NSE’s …

夜上海论坛

ixigo in ‘wait and watch mode’ for Rs 1,600-crore IPO

Online travel aggregator ixigo, which received a regulatory nod for its proposed Rs 1,600-crore IPO in December last year, is still in a ‘wait and watch mode’ for its public market debut even as the start-up reported a 184% y-o-y increase in revenue from operations for the financial year ended March 2022. Aloke Bajpai, Group …

夜上海论坛

6 key themes to help India’s corporate earnings beat emerging markets; check preferred sector stocks to buy

India’s economy and corporate earnings growth is expected to outpace other large emerging markets helped by six structural themes, said analysts at Bank of America Securities (BofA). Forecasting strong growth for the country, analysts are bullish on domestic cyclical sectors. “We … remain optimistic on domestic cyclical sectors such as Financials/Industrials/select Autos. We believe domestic …

夜上海论坛

Zydus Lifesciences begins Phase II trial of novel drug to treat fatal motor neuron disease

Zydus announced on Wednesday that it has received permission from CDSCO, India, to initiate the Phase II clinical study of NLRP3 inhibitor “ZYIL1” in patients with Amyotrophic Lateral Sclerosis (ALS). “Zydus has always aimed at improving the quality of life of patients through its life-changing discoveries. This study is a positive step in this direction …

夜上海论坛

Tata group stock gearing for gains, charts show; share price may rally 14% in 3 months

Indian equity markets started the week with losses amid weak global cues. S&P BSE Sensex was down more than 300 points or 0.50% to give up 59,300, while NSE Nifty 50 index fell 150 points or 0.48% to 17,600. According to analysts, the overall trend remains strongly bullish, however, further profit booking is to be …

夜上海论坛

Nifty may hit 17500 in coming weeks; SBI, Reliance, Tata Motors, Bharat Dynamics among top near-term picks

Indian equity markets extended gains on Monday amid positive global cues. S&P BSE Sensex was up more than 200 points or 0.38% to sit above 57,800 while NSE Nifty 50 index above 17,200, up 0.28%. Last week, equity benchmarks maintained their winning streak over a second consecutive week buoyed by firm global cues. The Nifty …

夜上海论坛

Colgate-Palmolive India rating: Hold | Topline remains the primary concern

While we continue to like Colgate as the dominant force in the oral care segment with large scale and superior economics, value creation and multiple re-rating are very sensitive to the sustained recovery in volume growth. 1) Topline growth remains subdued: With sales growth stuck in mid-to-low-single digits, volume growth has been stubbornly weak for …

浙ICP备15045783号-4